Sheppard Mullin Richter & Hampton LLP
6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine
Provided are imidazopyrazine compounds, particularly including 6-(benzo[d]thiazol-5-yl)-N-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine, structure below, and methods and formulations for their use in inhibiting Spleen Tyrosine Kinase in treating conditions including B-cell lymphomas or leukemias and inflammatory conditions:
Gilead Connecticut, Inc.
G G A C C C A A A A A A C A A A A A C A A A A A C
G01N G01N A61P C07D C07D C07D A61P A61P A61P A61P A61P A61P C12Q A61P A61K A61P A61P A61P C07D A61P A61P A61P A61P A61P C07D
inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Kevin S. James P. Antonio J. M. Zhongdong David M. Douglas G. Scott A. Jeffrey E. Soumya Peter A. Seung H. Jianjun
Currie Harding Barbosa, Jr. Zhao Armistead Stafford Mitchell Kropf Mitra Blomgren Lee Xu